Skip to main content
. 2021 May 25;11:10919. doi: 10.1038/s41598-021-90397-y

Table 4.

Detected irAEs in the study cohort.

irAE Grade of severity (CTCAE) PD or response group Discontinuation of treatment
Hypothyroidism 1–2 Response No
Hypothyroidism 1 Response No
Hypothyroidism 2 PD No
Exacerbation of a rheumatic arthritis 2 Response No
Pneumonitis 1–2 PD No

irAE immune related adverse events.